Qualigen Therapeutics, Inc.

The momentum for this stock is not very good. Qualigen Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Qualigen Therapeutics, Inc..

News

Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Globe Newswire New York, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC ( Univest ), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York...\n more…

Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering

Globe Newswire CARLSBAD, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the Company ) today announced the closing of its previously announced public offering of 14,724,058...\n more…

Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering

Globe Newswire CARLSBAD, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the Company ) today announced the pricing of a public offering of 14,724,058 shares of common...\n more…

QLGN Stock Earnings: Qualigen Therapeutics Reported Results for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nQualigen Therapeutics just reported results for the second quarter of 2024.\nThe post QLGN Stock Earnings: Qualigen Therapeutics Reported...\n more…

Qualigen Therapeutics (NASDAQ:QLGN) Trading Down 3.2%

Zolmax Qualigen Therapeutics, Inc. (NASDAQ:QLGN - Get Free Report)'s share price dropped 3.2% during mid-day trading on Thursday . The stock traded as low as $0.19 and last traded at $0.20. Approximately...\n more…

Qualigen Therapeutics Secures Loan and Expands Equity

TipRanks Financial Blog Earnings Calendar Dividend Calendar Economic Calendar IPO Calendar Stock Splits Stock Buybacks Market Holidays\n more…